Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 2
2019 4
2020 2
2021 4
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.
Fischer U, Kaesmacher J, Strbian D, Eker O, Cognard C, Plattner PS, Bütikofer L, Mordasini P, Deppeler S, Pereira VM, Albucher JF, Darcourt J, Bourcier R, Benoit G, Papagiannaki C, Ozkul-Wermester O, Sibolt G, Tiainen M, Gory B, Richard S, Liman J, Ernst MS, Boulanger M, Barbier C, Mechtouff L, Zhang L, Marnat G, Sibon I, Nikoubashman O, Reich A, Consoli A, Lapergue B, Ribo M, Tomasello A, Saleme S, Macian F, Moulin S, Pagano P, Saliou G, Carrera E, Janot K, Hernández-Pérez M, Pop R, Schiava LD, Luft AR, Piotin M, Gentric JC, Pikula A, Pfeilschifter W, Arnold M, Siddiqui AH, Froehler MT, Furlan AJ, Chapot R, Wiesmann M, Machi P, Diener HC, Kulcsar Z, Bonati LH, Bassetti CL, Mazighi M, Liebeskind DS, Saver JL, Gralla J; SWIFT DIRECT Collaborators. Fischer U, et al. Lancet. 2022 Jul 9;400(10346):104-115. doi: 10.1016/S0140-6736(22)00537-2. Lancet. 2022. PMID: 35810756 Clinical Trial.
Role of dopamine agonists in Parkinson's disease therapy.
Woitalla D, Buhmann C, Hilker-Roggendorf R, Höglinger G, Koschel J, Müller T, Weise D. Woitalla D, et al. Among authors: hilker roggendorf r. J Neural Transm (Vienna). 2023 Jun;130(6):863-873. doi: 10.1007/s00702-023-02647-0. Epub 2023 May 11. J Neural Transm (Vienna). 2023. PMID: 37165120 Review.
COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany.
Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C, Petzold GC, Piccininni M, Poli S, Röhrig R, Steinmetz H, Thiele T, Kurth T; German Society of Neurology SARS-CoV-2 Vaccination Study Group. Schulz JB, et al. Ann Neurol. 2021 Oct;90(4):627-639. doi: 10.1002/ana.26172. Epub 2021 Aug 23. Ann Neurol. 2021. PMID: 34288044 Free PMC article.
Interaction between intravenous thrombolysis and clinical outcome between slow and fast progressors undergoing mechanical thrombectomy: a post-hoc analysis of the SWIFT-DIRECT trial.
Marnat G, Kaesmacher J, Buetikofer L, Sibon I, Saleme S, Pop R, Henon H, Michel P, Mazighi M, Kulcsar Z, Janot K, Machi P, Pikula A, Gentric JC, Hernández-Pérez M, Krause LU, Turc G, Liebeskind DS, Gralla J, Fischer U; SWIFT-DIRECT investigators. Marnat G, et al. J Neurointerv Surg. 2023 Dec 19;16(1):45-52. doi: 10.1136/jnis-2023-020113. J Neurointerv Surg. 2023. PMID: 37055063 Clinical Trial.
Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's Disease.
Michels J, van der Wurp H, Kalbe E, Rehberg S, Storch A, Linse K, Schneider C, Gräber S, Berg D, Dams J, Balzer-Geldsetzer M, Hilker-Roggendorf R, Oberschmidt C, Baudrexel S, Witt K, Schmidt N, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Spottke A, Roeske S, Wüllner U, Wittchen HU, Riedel O, Kassubek J, Dodel R, Schulz JB, Costa AS, Reetz K. Michels J, et al. Among authors: hilker roggendorf r. J Parkinsons Dis. 2022;12(3):905-916. doi: 10.3233/JPD-212787. J Parkinsons Dis. 2022. PMID: 35068416
Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.
Charissé D, Erus G, Pomponio R, Gorges M, Schmidt N, Schneider C, Liepelt-Scarfone I, Riedel O, Reetz K, Schulz JB, Berg D, Storch A, Witt K, Dodel R, Kalbe E, Kassubek J, Hilker-Roggendorf R, Baudrexel S. Charissé D, et al. Among authors: hilker roggendorf r. Neurobiol Aging. 2022 Jan;109:31-42. doi: 10.1016/j.neurobiolaging.2021.08.020. Epub 2021 Sep 6. Neurobiol Aging. 2022. PMID: 34649002
Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes.
Lampe L, Niehaus S, Huppertz HJ, Merola A, Reinelt J, Mueller K, Anderl-Straub S, Fassbender K, Fliessbach K, Jahn H, Kornhuber J, Lauer M, Prudlo J, Schneider A, Synofzik M, Danek A, Diehl-Schmid J, Otto M; FTLD-Consortium Germany; Villringer A, Egger K, Hattingen E, Hilker-Roggendorf R, Schnitzler A, Südmeyer M, Oertel W; German Atypical Parkinson Consortium Study Group; Kassubek J, Höglinger G, Schroeter ML. Lampe L, et al. Among authors: hilker roggendorf r. Alzheimers Res Ther. 2022 May 3;14(1):62. doi: 10.1186/s13195-022-00983-z. Alzheimers Res Ther. 2022. PMID: 35505442 Free PMC article.
Correction to: Role of dopamine agonists in Parkinson's disease therapy.
Woitalla D, Buhmann C, Hilker-Roggendorf R, Höglinger G, Koschel J, Müller T, Weise D. Woitalla D, et al. Among authors: hilker roggendorf r. J Neural Transm (Vienna). 2023 Sep 13. doi: 10.1007/s00702-023-02695-6. Online ahead of print. J Neural Transm (Vienna). 2023. PMID: 37702775 No abstract available.
Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease.
Lueken U, Evens R, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Gräber-Sultan S, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O. Lueken U, et al. Among authors: hilker roggendorf r. Int J Methods Psychiatr Res. 2017 Dec;26(4):e1564. doi: 10.1002/mpr.1564. Epub 2017 Apr 18. Int J Methods Psychiatr Res. 2017. PMID: 28418163 Free PMC article.
20 results